The Scleroderma Research Foundation Announces the Launch of the CONQUEST Trial Platform and IND Clearance

/PRNewswire/ -- The Scleroderma Research Foundation (SRF), the nation's largest non-profit funder of scleroderma research, today announced that the FDA has...

Related Keywords

United States ,American ,Ioannis Sapountzis ,Luke Evnin ,Shari Annes ,Drug Administration ,Animal Health ,Boehringer Ingelheim ,Head Of Global Development ,Research Development ,Mannes Associates ,Scleroderma Research Foundation ,Interstitial Lung Disease Secondary ,Investigational New Drug ,Therapy Designation ,Orphan Drug Designation ,Global Head ,Therapeutic Areas ,Global Development ,Interstitial Lung Disease ,Scleroderma Research ,Scientific Advisory Board ,African American ,Human Pharma ,